Dorff, Tanya B <br/><br/>
Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer.  [electronic resource] 

 -  Current opinion in urology  Jul 2013 
 - 366-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1473-6586 
<br/><br/><label>Standard No.: </label>10.1097/MOU.0b013e328361d467  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--adverse effects<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Chemoradiotherapy--adverse effects<br/>Humans<br/>Kallikreins--blood<br/>Male<br/>Neoadjuvant Therapy<br/>Neoplasms, Hormone-Dependent--blood<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy--adverse effects<br/>Prostatic Neoplasms--blood<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome